These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 14671637)
1. Flavopiridol: where do we stand in chronic lymphocytic leukemia? Lin TS; Porcu P Leukemia; 2004 Feb; 18(2):243-6. PubMed ID: 14671637 [No Abstract] [Full Text] [Related]
2. Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia. Billard C; Kern C; Tang R; Ajchenbaum-Cymbalista F; Kolb JP Leukemia; 2003 Dec; 17(12):2435-43. PubMed ID: 14523476 [TBL] [Abstract][Full Text] [Related]
4. Flavopiridol in the treatment of chronic lymphocytic leukemia. Christian BA; Grever MR; Byrd JC; Lin TS Curr Opin Oncol; 2007 Nov; 19(6):573-8. PubMed ID: 17906454 [TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia: a niche for flavopiridol? Brown JR Clin Cancer Res; 2005 Jun; 11(11):3971-3. PubMed ID: 15930331 [No Abstract] [Full Text] [Related]
6. Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805. Byrd JC; Peterson BL; Gabrilove J; Odenike OM; Grever MR; Rai K; Larson RA; Clin Cancer Res; 2005 Jun; 11(11):4176-81. PubMed ID: 15930354 [TBL] [Abstract][Full Text] [Related]
7. Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism. Pepper C; Thomas A; Fegan C; Hoy T; Bentley P Leuk Lymphoma; 2003 Feb; 44(2):337-42. PubMed ID: 12688354 [TBL] [Abstract][Full Text] [Related]
8. The inducible NO synthase is downregulated during apoptosis of malignant cells from B-cell chronic lymphocytic leukemia induced by flavopiridol and polyphenols. Billard C; Quiney C; Tang R; Kern C; Ajchenbaum-Cymbalista F; Dauzonne D; Kolb JP Ann N Y Acad Sci; 2003 Dec; 1010():381-3. PubMed ID: 15033756 [TBL] [Abstract][Full Text] [Related]
9. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Quiney C; Dauzonne D; Kern C; Fourneron JD; Izard JC; Mohammad RM; Kolb JP; Billard C Leuk Res; 2004 Aug; 28(8):851-61. PubMed ID: 15203283 [TBL] [Abstract][Full Text] [Related]
10. Flavopiridol in chronic lymphocytic leukemia: a concise review. Christian BA; Grever MR; Byrd JC; Lin TS Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S179-85. PubMed ID: 19778838 [TBL] [Abstract][Full Text] [Related]
11. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia. Wiernik PH Expert Opin Investig Drugs; 2016 Jun; 25(6):729-34. PubMed ID: 26998706 [TBL] [Abstract][Full Text] [Related]
12. Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol. Zaher M; Akrout I; Mirshahi M; Kolb JP; Billard C Leukemia; 2009 Mar; 23(3):594-6. PubMed ID: 18784742 [No Abstract] [Full Text] [Related]
13. Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features. Woyach JA; Lozanski G; Ruppert AS; Lozanski A; Blum KA; Jones JA; Flynn JM; Johnson AJ; Grever MR; Heerema NA; Byrd JC Leukemia; 2012 Jun; 26(6):1442-4. PubMed ID: 22289993 [No Abstract] [Full Text] [Related]
14. Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium. Hussain SR; Lucas DM; Johnson AJ; Lin TS; Bakaletz AP; Dang VX; Viatchenko-Karpinski S; Ruppert AS; Byrd JC; Kuppusamy P; Crouser ED; Grever MR Blood; 2008 Mar; 111(6):3190-9. PubMed ID: 18192508 [TBL] [Abstract][Full Text] [Related]
15. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes. Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875 [TBL] [Abstract][Full Text] [Related]
16. The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill. Pepper CJ; Hambly RM; Fegan CD; Delavault P; Thurston DE Cancer Res; 2004 Sep; 64(18):6750-5. PubMed ID: 15374993 [TBL] [Abstract][Full Text] [Related]
17. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed. Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498 [TBL] [Abstract][Full Text] [Related]
18. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Shapiro GI; Koestner DA; Matranga CB; Rollins BJ Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362 [TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions. Tiscornia AC; Cayota A; Landoni AI; Brito C; Oppezzo P; Vuillier F; Robello C; Dighiero G; GabĂșs R; Pritsch O Leukemia; 2004 Jan; 18(1):48-56. PubMed ID: 14574328 [TBL] [Abstract][Full Text] [Related]
20. Hydrostatic pressure induces apoptosis in human chondrocytes from osteoarthritic cartilage through up-regulation of tumor necrosis factor-alpha, inducible nitric oxide synthase, p53, c-myc, and bax-alpha, and suppression of bcl-2. Islam N; Haqqi TM; Jepsen KJ; Kraay M; Welter JF; Goldberg VM; Malemud CJ J Cell Biochem; 2002; 87(3):266-78. PubMed ID: 12397608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]